Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Hiroshi Aochi is active.

Publication


Featured researches published by Hiroshi Aochi.


Transfusion | 2018

Distinct effects of daratumumab on indirect and direct antiglobulin tests: a new method employing 0.01 mol/L dithiothreitol for negating the daratumumab interference with preserving K antigenicity (Osaka method): 0.01 MOL/L DTT FOR THE DARA INTERFERENCE

Mika Hosokawa; Hirokazu Kashiwagi; Kotarosumitomo Nakayama; Mikiko Sakuragi; Mayumi Nakao; Tamayo Morikawa; Tomoko Kiyokawa; Hiroshi Aochi; Keisuke Nagamine; Hirohiko Shibayama; Yoshiaki Tomiyama

There is an increasing demand for daratumumab (DARA), an immunoglobulin (Ig)G1κ monoclonal antibody (MoAb) that recognizes CD38, to manage relapsed or refractory multiple myeloma (MM) patients. However, DARA leads to positive and panreactive agglutination reactions in indirect antiglobulin tests (IATs) in vitro (the DARA interference). In addition, effects of DARA on red blood cells (RBCs) in vivo remains elusive.


Journal of the Japan Society of Blood Transfusion | 2000

Report on ABO-Incompatible Transfusions in 12 University Hospitals in Kinki Districts.

Yoshiyuki Kurata; Tomoko Kiyokawa; Hiroshi Aochi; Keisuke Nagamine; Satoru Hayashi; Machiko Oshida

We investigated the incidence and the causes of ABO-incompatible transfusion in 12 university hospitals in the Kinki district during the 5-year period from 1993 through 1997. Over 5 years, 648, 553 units of red cell components (RBC) and 2, 545, 880 units of fresh frozen plasma (FFP) or platelet concentrate (PC) were transfused, and a total of 26 ABO-incompatible transfusions occurred. Incompatible RBC were transfused to 17 patients and FFP or PC were transfused to the remaining 9 patients. In cases of RBC transfusion, half of errors (8 cases) were due to misidentification of blood units and the other half of errors (8 cases) were due to incorrect typing. Twenty of 26 errors occurred during night shifts and the majority of errors occurred in the ward (17 cases) or operating room (5 cases). Various measures were taken to prevent ABO-incompatible transfusion at the participating universities. We conclude that continued data collection and analysis are necessary to prevent ABO-incompatible transfusion.


Journal of the Japan Society of Blood Transfusion | 1990

A case of immune hemolytic anemia due to "auto" anti-A1 antibody induced by group O homograft in renal transplantation recipient.

Satoru Hayashi; Hiroshi Aochi; Keisuke Nagamine; Machiko Oshida; Kazue Yamamoto; Yoshiyuki Kurata; Shirou Takahara; Michio Ishibashi; Takao Sonoda

A case of severe auto-immune hemolytic anemia after a living, ABO-incompatible renal transplantation is reported.The recipient, a 34 years old man, blood group A1, Rh0 (D) positive receieved a renal transplant from father whose blood group O, Rh0(D) positive donor. Cyclosporine, prednisolone and mizoribine were used for immunosuppresion.The recipient devloped severe immune hemolytic anemia within 2 weeks of renal transplantation. The recipients serum contained anti-A1 IgG autoantibody and anti-B IgG antibody on day 18 post-transplantation. The IgG subclass of these antibodies was IgG3.


Journal of the Japan Society of Blood Transfusion | 1989

ELISA for detection of red cell antibodies using red cell ghosts coated plates. The detection of Rh and other antibodies.

Keisuke Nagamine; Hiroshi Aochi; Satoru Hayashi; Machiko Oshida; Yoshiyuki Kurata

An ELISA using micro-plates coated with red cell ghosts was developed for analysis of red cell antibodies.Antibodies against MNSs, Kell, Duffy and Kidd antigens were detected using this ELISA. Rh antibodies in patients sera could be also detected by this assay, but the elution technique was needed when the titer of antibody was low.We considered that this assay was quantitative, objective and sensitive compared with indirect antiglobulin test, and easy to perform compared with ELISA of tube method using red cell suspensions.


Japanese Journal of Transfusion and Cell Therapy | 2017

DTT TREATMENT FOR STRONG AUTOAGGLUTINATION OBSERVED IN A PATIENT WITH LOW-TITER CAD

Mika Hosokawa; Kotarousumitomo Nakayama; Mikiko Sakuragi; Mayumi Nakao; Tamayo Morikawa; Tomoko Kiyokawa; Hiroshi Aochi; Keisuke Nagamine; Hisashi Kato; Yoshiaki Tomiyama


International Journal of Hematology | 2014

A case of neonatal alloimmune thrombocytopenia in the presence of both anti-HPA-4b and anti-HPA-5b antibody: clinical and serological analysis of the subsequent pregnancy

Tomoko Kiyokawa; Yangsook Koh; Kazuya Mimura; Kotarosumitomo Nakayama; Mika Hosokawa; Mikiko Sakuragi; Tamayo Morikawa; Mayumi Nakao; Hiroshi Aochi; Yasuo Fukumori; Takeshi Kanagawa; Keisuke Nagamine; Tadashi Kimura; Yoshiaki Tomiyama


Japanese Journal of Transfusion and Cell Therapy | 2013

CLINICAL COURSE OF ALLOIMMUNIZED PATIENTS AFTER RED BLOOD CELL TRANSFUSION

Mikiko Sakuragi; Tomoko Kiyokawa; Mika Hosokawa; Tomomi Kiyama; Mayumi Nakao; Tamayo Ikeda; Machiko Oshida; Hiroshi Aochi; Keisuke Nagamine; Yoshiaki Tomiyama


Japanese Journal of Transfusion and Cell Therapy | 2011

REDUCING DISCARDED BLOOD COMPONENTS: ANALYSIS OF REASONS FOR DISCARD OVER THE PAST 6 YEARS

Tamayo Ikeda; Machiko Oshida; Tomomi Kiyama; Mikiko Sakuragi; Mika Tateno; Mayumi Nakao; Tomoko Kiyokawa; Hiroshi Aochi; Keisuke Nagamine; Yoshiaki Tomiyama


Japanese Journal of Transfusion and Cell Therapy | 2018

A CASE OF NEONATAL ALLOIMMUNE THROMBOCYTOPENIA IN THE PRESENCE OF THREE DIFFERENT anti-HPA ANTIBODIES: HPA-4b, HPA-5a, AND HPA-15b ANTIBODIES

Tomoko Kiyokawa; Yongsook Koh; Tomoichiro Kuwazuru; Kotarosumitomo Nakayama; Mika Hosokawa; Mikiko Sakuragi; Tamayo Morikawa; Mayumi Nakao; Hiroshi Aochi; Hiroyuki Ishii; Yasuto Kinose; Keisuke Nagamine; Tadashi Kimura; Yoshiaki Tomiyama


Journal of the Japan Society of Blood Transfusion | 1998

Nonhemolytic transfusion reactions and anti-plasma protein antibodies: Relationship between urticaria, itching and anti-C2, anti-C4 antibodies.

Satoru Hayashi; Tomoko Kiyokawa; Hiroshi Aochi; Keisuke Nagamine; Machiko Oshida; Yoshiaki Tomiyama; Yoshiyuki Kurata

Collaboration


Dive into the Hiroshi Aochi's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge